Dean Emeritus and Co-Chair of Board of Overseers, Weill Cornell Medical College

As you know, Esperion is focused on developing and commercializing therapies for the treatment of patients with hypercholesterolemia who are not adequately controlled by currently available lipid-modifying therapies. Like any medical innovation, the journey of bempedoic acid started long before Esperion with the earliest identification of LDL-cholesterol (LDL-C) more than a century ago. So as… Read More

Buongiorno from the ESC Congress! Earlier this week we had the opportunity to attend the 2016 European Society of Cardiology (ESC) Congress in Rome. ESC has become the largest cardiology meeting in the world with more than 32,000 physicians and other healthcare care professionals in attendance this year. This is one of the most important… Read More

Perhaps, like me, you’ve been watching the Rio 2016 Summer Olympic Games, reading about the Olympics online and in print, and talking about the Olympics with friends and co-workers. The Olympics have been exciting to watch – and exhausting to keep up with! Dawn now considers herself an “Olympics widow”. There are always inspiring Olympic… Read More

“The most important reason or purpose for someone or something’s existence.” Bonjour le tout, I am writing to you following a trip to Paris, France with my wife, Dawn, late last month. Visiting Paris had been on Dawn’s “bucket-list” for many years, and we took advantage of the little time we have together and did… Read More

This is Tim Mayleben – CEO of Esperion Therapeutics with some thoughts I wanted to share. Please read on if you’re interested. First, a little history. Esperion Therapeutics was founded by my good friend and colleague, Roger Newton. You may remember that Roger was the co-discoverer and product champion for Lipitor, the best-selling LDL-cholesterol lowering… Read More

By now you’ve read the headlines about the high cost of the new cholesterol lowering drugs. We’ve been bombarded with commentary, articles and opinion pieces on these drugs and their high prices. The PCSK9 inhibitors – injectable, biologic drugs that dramatically lower LDL-cholesterol – appear to be very efficacious. But these drugs are priced at… Read More